OTC Drug Office Proposal Aimed At Balancing Funds, Workload
This article was originally published in The Rose Sheet
Executive Summary
The creation of an FDA Office of Non-Prescription Products is part of a proposed reorganization of the Center for Drug Evaluation & Research Office of New Drugs seeking to balance allocation of resources with the office's workload, according to a proposal by OND Director John Jenkins, MD, released by the agency Oct. 28